Abstract: Methods and systems for issuing a security unit to an individual, after determining the eligibility of the individual by image recognition, are disclosed. The security unit, such as a security pass or a key, can be issued to the individual by an issuing module after the individual has been recognized by a recognition system, provided various eligibility criteria are met.
Abstract: An Ethernet Automatic Protection Switching (APS) Bridge Selector is provided for supporting SDH/SONET APS standard functionality in Ethernet Networks. In accordance with one embodiment, an Ethernet APS Bridge Selector is provided for bridge, selector, and switchover functionality for a plurality of Physical Layer (PHY) hardware devices. The Ethernet APS Bridge Selector provides support for any Media Access Control (MAC) hardware to PHY interface/interconnect. The Ethernet APS Bridge Selector can be managed via interfaces, signals and/or control/register interfaces.
Abstract: CTLA4-immunoglobulin fusion proteins having modified immunoglobulin constant region-mediated effector functions, and nucleic acids encoding the fusion proteins, are described. The CTLA4-immunoglobulin fusion proteins comprise two components: a first peptide having a CTLA4 activity and a second peptide comprising an immunoglobulin constant region which is modified to reduce at least one constant region-mediated biological effector function relative to a CTLA4-IgG1 fusion protein. The nucleic acids of the invention can be integrated into various expression vectors, which in turn can direct the synthesis of the corresponding proteins in a variety of hosts, particularly eukaryotic cells. The CTLA4-immunoglobulin fusion proteins described herein can be administered to a subject to inhibit an interaction between a CTLA4 ligand (e.g., B7-1 and/or B7-2) on an antigen presenting cell and a receptor for the CTLA4 ligand (e.g.
Type:
Grant
Filed:
January 8, 1999
Date of Patent:
September 3, 2002
Assignee:
Repligen Corporation
Inventors:
Gary S. Gray, Jerry Carson, Kashi Javaherian, Paul D. Rennert, Sandra Silver
Abstract: Isolated DNA encoding allergens of Dermatophagoides (house dust mites) particularly of the species Dermatophagoides farinae and Dermatophagoides pteronyssinus, which are protein allergens or peptides which include at least one epitope of the protein allergen. In particular, DNA encoding two major D. farinae allergens, Der f I and Der f II and DNA encoding a D. pteronyssinus allergen, Der p I. In addition, the proteins or peptides encoded by the isolated DNA, their use as diagnostic and therapeutic reagents and methods of diagnosing and treating sensitivity to house dust mite allergens.
Type:
Grant
Filed:
June 7, 1995
Date of Patent:
November 14, 2000
Assignee:
ImmuLogic Pharmaceutical Corporation
Inventors:
Wayne Robert Thomas, Geoffrey A. Stewart, Keven J. Turner, Richard J. Simpson